BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1932745)

  • 21. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB; Puszkin EG; Sussman II; Mauss EA
    J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Uematsu T
    Circulation; 1997 Aug; 96(4):1299-304. PubMed ID: 9286962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-collagen interaction: inhibition by ristocetin and enhancement by von Willebrand factor-platelet binding.
    LaDuca FM; Bettigole RE; Bell WR; Robson EB
    Blood; 1986 Oct; 68(4):927-37. PubMed ID: 3489493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction.
    Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H
    Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions.
    Ross JM; McIntire LV; Moake JL; Rand JH
    Blood; 1995 Apr; 85(7):1826-35. PubMed ID: 7703489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor.
    Ozaki Y; Satoh K; Yatomi Y; Miura S; Fujimura Y; Kume S
    Biochim Biophys Acta; 1995 Apr; 1243(3):482-8. PubMed ID: 7537105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional analysis of a recombinant glycoprotein Ib alpha polypeptide which inhibits von Willebrand factor binding to the platelet glycoprotein Ib-IX complex and to collagen.
    Cruz MA; Petersen E; Turci SM; Handin RI
    J Biol Chem; 1992 Jan; 267(2):1303-9. PubMed ID: 1730650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
    Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
    Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
    Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex.
    Berndt MC; Du XP; Booth WJ
    Biochemistry; 1988 Jan; 27(2):633-40. PubMed ID: 2450575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
    Moake JL; Turner NA; Stathopoulos NA; Nolasco LH; Hellums JD
    J Clin Invest; 1986 Dec; 78(6):1456-61. PubMed ID: 3491092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor.
    Andrews RK; Bendall LJ; Booth WJ; Berndt MC
    Platelets; 1995; 6(5):252-8. PubMed ID: 21043709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
    J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
    De Marco L; Girolami A; Russell S; Ruggeri ZM
    J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox.
    Wu WB; Peng HC; Huang TF
    Thromb Haemost; 2001 Dec; 86(6):1501-11. PubMed ID: 11776320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
    Vicente V; Houghten RA; Ruggeri ZM
    J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.